Androgenic alopecia. Androgenic alopecia, unspecified
Conditions
Interventions
Intervention 1: Intervention group: Patients in the first intervention group will take 1 cc (equivalent to 20 drops) of 5% minoxidil solution twice a day for 9 months. Intervention 2: Intervention gro
Sponsors
Esfahan University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 45 Years
Inclusion criteria
Inclusion criteria: Confirmation of androgenic alopecia by two experienced dermatologists based on Hamilton diagnostic criteria Patient consent to participate in the study The intensity of hair loss in stage 2 to 5 according to Hamilton scale and in stages 1 and 2 according to Ludwig scale The duration of hair loss is less than 10 years
Exclusion criteria
Exclusion criteria: History or observation of allergies to any of the drugs minoxidil and flutamide History of heart disease and use of antihypertensive drugs Receiving systemic treatment for androgenic alopecia during the 6 months prior to the study Other types of alopecia such as alopecia areata, telogen effluvium, anagen effluvium and scarring alopecia of any systemic cutaneous disease
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Hair density. Timepoint: Pre-and post-intervention. Method of measurement: Hair polarizer.;Severity of hair loss. Timepoint: Pre-and post-intervention. Method of measurement: By a skilled physician based on Hamilton-Norwood scale for male pattern hair loss and Ludwig scale for female pattern hair loss. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactGita Faghihi
Esfahan University of Medical Sciences
Outcome results
None listed